Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Discover the latest science on glaucoma, vision, and longevity. Each episode explores evidence-based supplements for eye health, healthy aging, and lifespan extension. Original articles backed by real scientific research. All source links available at visualfieldtest.com, where you can also take a free visual field test online. Subscribe for weekly insights on glaucoma treatment, glaucoma prevention, vision supplements, and longevity research that could protect your sight and extend your healthspan.
MEDICAL DISCLAIMER:
This podcast is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. The content presented should not replace professional medical consultation.
Glaucoma is a serious condition that can lead to permanent vision loss. Never stop or modify prescribed treatments without consulting your ophthalmologist or healthcare provider.
The supplements and research discussed are for informational purposes only. Individual results may vary, and supplements are not FDA-approved to treat, cure, or prevent any disease.
Always consult a qualified healthcare professional before starting any new supplement regimen, especially if you have existing eye conditions or are taking medications.
The visual field test available at visualfieldtest.com is a screening tool only and does not replace comprehensive eye exams by a licensed professional.
| Episode | Date |
|---|---|
|
Nocturnal hypotension, sleep apnea, and ocular perfusion: continuous monitoring studies
|
May 15, 2026 |
|
Economics of high-frequency home monitoring versus clinic-based perimetry
|
May 14, 2026 |
|
Color and contrast-specific perimetry to probe retinal ganglion cell subtype vulnerability
|
May 13, 2026 |
|
Inequities in access to visual field testing and their outcome consequences
|
May 12, 2026 |
|
Low-Carb Diets and Nocturnal Blood Pressure Dips: Ocular Perfusion Risks and Benefits
|
May 11, 2026 |
|
Macronutrient Patterns and Intraocular Pressure: A Systematic Evaluation
|
May 10, 2026 |
|
Personalized Nutrition in Glaucoma: Nutrigenomic Interactions with Macronutrient Metabolism
|
May 09, 2026 |
|
Medium-Chain Triglycerides vs Long-Chain Fats: Rapid Ketosis and Visual Function
|
May 08, 2026 |
|
Protein Intake, Homocysteine, and Pseudoexfoliation Glaucoma Risk
|
May 07, 2026 |
|
mTOR/Autophagy Modulation by Amino Acids in RGC Degeneration
|
May 05, 2026 |
|
NR vs NMN vs Nicotinamide for Glaucoma: Which NAD+ Booster Has the Strongest Evidence?
|
May 04, 2026 |
|
How Useful Is OCT at Each Stage of Glaucoma?
|
May 03, 2026 |
|
New Glaucoma Treatments in 2026: What Patients Should Know About Longer-Lasting Eye Pressure Control
|
May 02, 2026 |
|
Endothelin-1 Peptide and Glaucoma: Targeting a Problem Pathway
|
Apr 28, 2026 |
|
Substance P, Pain, and Neuroinflammation in Glaucoma
|
Apr 26, 2026 |
|
GLP-1 Peptides and Glaucoma Risk: What We Know and What to Watch
|
Apr 24, 2026 |
|
Nerve Growth Factor–Based Peptides and Optic Nerve Protection
|
Apr 23, 2026 |
|
Heat shock protein-derived peptides and autoimmunity in glaucoma
|
Apr 22, 2026 |
|
Endothelin pathway peptides and optic nerve head ischemia in glaucoma
|
Apr 21, 2026 |
|
MOTS-c and Glaucoma: A Mitochondrial Signal With Bigger Implications Than Eye Pressure?
|
Apr 20, 2026 |
|
Senolytics and the Glaucoma Niche: Clearing Old Cells for Longer-Life Signals
|
Apr 19, 2026 |
|
Ketogenic Signals and Beta-Hydroxybutyrate: IOP, Neuroprotection, and Longevity Intersections
|
Apr 18, 2026 |
|
The Glaucoma Energy Crisis: How Pyruvate Rescues Failing Eyes (And Why Your Fitness Level Matters)
|
Apr 17, 2026 |
|
Photobiomodulation (670 nm) for Aging Retina: Lifespan Signals from Flies to Mammals
|
Apr 16, 2026 |
|
What’s New in Glaucoma Research in April 2026? What Patients Should Know
|
Apr 15, 2026 |
|
A New Clue in Glaucoma: Leaky Blood Vessels May Damage Vision
|
Apr 14, 2026 |
|
April 2026 Glaucoma Trial Launches: A Global Landscape Review
|
Apr 13, 2026 |
|
April 2026 Glaucoma Trial Launches: A Global Landscape Review
|
Apr 13, 2026 |
|
Therapeutic Mechanisms Debuting in April 2026 Glaucoma Trials
|
Apr 12, 2026 |
|
Gene- and Cell-Based Therapies Entering Glaucoma Trials in April 2026
|
Apr 11, 2026 |
|
Home Tonometers and Contact Lens Sensors in April 2026 Protocols
|
Apr 09, 2026 |
|
Washout and Rescue Protocols in April 2026 IOP-Lowering Studies
|
Apr 07, 2026 |
|
Hyperbaric Oxygen Therapy and Glaucoma: Mechanistic Rationale and Biological Plausibility
|
Apr 04, 2026 |
|
Oxidative Stress, Hormesis, and the Hyperoxia Paradox in Glaucoma
|
Apr 02, 2026 |
|
Soccer and Glaucoma: Endurance Gains Amid Collision Risks
|
Apr 02, 2026 |
|
Hiking and Glaucoma: Terrain, Altitude, and Sun Exposure
|
Apr 01, 2026 |
|
Running and Jogging with Glaucoma: Balancing Cardiovascular Gains and IOP Fluctuations
|
Apr 01, 2026 |
|
Road Cycling and Glaucoma: Aerobic Advantage with Posture and Safety Considerations
|
Mar 31, 2026 |
|
Snorkeling and Glaucoma: Gentle Aquatic Activity with Mask and Sunlight Considerations
|
Mar 30, 2026 |
|
SCUBA Diving and Glaucoma: Pressure, Perfusion, and Post-Surgical Precautions
|
Mar 30, 2026 |
|
Lap Swimming and Glaucoma: Cardiorespiratory Benefits vs. Goggle and Head Position Issues
|
Mar 29, 2026 |
|
Basketball and Glaucoma: Dynamic Cardio with Contact and Glare Considerations
|
Mar 28, 2026 |
|
General Resistance Training and Glaucoma: Building Strength While Managing IOP Spikes
|
Mar 27, 2026 |
|
High-Intensity Interval Training (HIIT) and Glaucoma: Short Bouts, Big Questions
|
Mar 26, 2026 |
|
Can Eye Blood Vessel Changes Warn of Future Glaucoma Damage Before Vision Tests Turn Abnormal?
|
Mar 25, 2026 |
|
Does Angle-Closure Risk Build Up Earlier in Life Than People Think?
|
Mar 24, 2026 |
|
Can Exercise, Better Sleep, and Stress Reduction Help in Glaucoma? What a New March 2026 Study Suggests
|
Mar 23, 2026 |
|
If One Person in the Family Has Glaucoma, Should Everyone Else Get Checked?
|
Mar 22, 2026 |
|
A New Glaucoma Drug Study Is Starting: Could an Oral Cannabinoid Help Lower Eye Pressure?
|
Mar 21, 2026 |
|
What Was Actually New in Glaucoma This Month? A Plain-English Guide to the Most Important March 2026 Updates
|
Mar 20, 2026 |
|
Why Is It So Hard to Prove a Treatment Protects the Optic Nerve in Glaucoma?
|
Mar 19, 2026 |
|
A New Way to Read Eye Scans in Glaucoma: Can 3D Nerve Fiber Shape Improve Detection?
|
Mar 18, 2026 |
|
Could Better Scan Databases Help Catch Glaucoma Earlier? What a New March 2026 Study Found
|
Mar 17, 2026 |
|
Does Eye Pressure Damage Show Up Before Vision Gets Worse? A New March 2026 Glaucoma Study Explains the Time Lag
|
Mar 17, 2026 |
|
A Cataract Lens That Also Treats Glaucoma? What the New BIM-IOL Study Means for Patients
|
Mar 16, 2026 |
|
Why Vision Restoration Is So Much Harder in Glaucoma Than in Some Other Eye Diseases
|
Mar 14, 2026 |
|
Eyes Wide Open: How Karpathy's Autoresearch Framework Could Democratize Glaucoma Research — A Blueprint for Patient-Led, AI-Driven Discovery in Vision Restoration
|
Mar 13, 2026 |
|
Can a Light-Sensing Drug Help Restore Vision? Understanding the Newest KIO-301 Research
|
Mar 12, 2026 |
|
A Treatment That Helped Some Blind Patients See More Light and Shape: What MCO-010 Means for Vision Restoration
|
Mar 11, 2026 |
|
Helping New Cells Survive: How Tiny Drug Carriers May Support Future Vision Repair in Glaucoma
|
Mar 10, 2026 |
|
Could Cell Transplants One Day Restore Vision in Glaucoma? A New Study Looks at One Major Roadblock
|
Mar 09, 2026 |
|
A New Glaucoma Implant Study: Can It Protect Vision, and Can It Bring Lost Vision Back?
|
Mar 08, 2026 |
|
What Is a 24-2 Visual Field Test
|
Mar 06, 2026 |
|
How Fast Does Glaucoma Progress
|
Mar 05, 2026 |
|
Perioperative Pitfalls: Supplements That Raise Bleeding Risk in Glaucoma Surgery
|
Mar 04, 2026 |
|
Does Diabetes Cause Glaucoma
|
Mar 03, 2026 |
|
Can You Have Glaucoma in One Eye
|
Mar 01, 2026 |
|
Zinc, Copper, and Optic Neuropathy: When Supplements Mimic Glaucoma Progression
|
Feb 27, 2026 |
|
How Long Does a Glaucoma Test Take
|
Feb 26, 2026 |
|
Which Is Worse Cataracts or Glaucoma
|
Feb 25, 2026 |
|
Does Glaucoma Cause Headaches
|
Feb 24, 2026 |
|
How to Test for Glaucoma
|
Feb 23, 2026 |
|
Is Glaucoma a Disability
|
Feb 22, 2026 |
|
Is Glaucoma Genetic
|
Feb 21, 2026 |
|
What Is Narrow Angle Glaucoma
|
Feb 20, 2026 |
|
What Are the Symptoms of Glaucoma
|
Feb 18, 2026 |
|
How to Prevent Glaucoma
|
Feb 17, 2026 |
|
What Does Glaucoma Look Like
|
Feb 16, 2026 |
|
What Causes Glaucoma
|
Feb 15, 2026 |
|
Magnesium and Glaucoma: A Systematic Review of Human Evidence
|
Feb 14, 2026 |
|
Antioxidant Vitamins and Minerals: Do A, C, E, Zinc, and Selenium Matter in Glaucoma?
|
Feb 13, 2026 |
|
Sodium, Blood Pressure, and Ocular Perfusion: Dietary Salt in Glaucoma Care
|
Feb 12, 2026 |
|
Soy Foods, Phytoestrogens, and Glaucoma in Women
|
Feb 11, 2026 |
|
Lifestyle Levers to Extend Visual Healthspan
|
Feb 11, 2026 |
|
Blue Zones and Centenarians: Ocular Phenotypes of Exceptional Agers
|
Feb 09, 2026 |
|
Metformin, Rapamycin, and Geroscience Drugs: Ocular Outcomes
|
Feb 07, 2026 |
|
ER-100 Clinical Trial for Glaucoma: What We Know So Far and What to Expect
|
Feb 06, 2026 |
|
Glaucoma Eye Drops, Dry Eye, and Sleep Quality: Exploring Hidden Connections and What Patients Can Do
|
Feb 06, 2026 |
|
The Ocular Microbiome, Inflammaging, and Surface Health
|
Feb 05, 2026 |
|
Methods of Visual Field Testing in Glaucoma: How They Differ and What Each Reveals
|
Feb 04, 2026 |
|
The Limitations of Visual Field Testing in Glaucoma: Frequency, Subjectivity, and What Gets Missed
|
Feb 03, 2026 |
|
Home Tonometry and Remote Monitoring in Glaucoma – A Patient-Centered Investigation
|
Feb 02, 2026 |
|
Predicting Glaucoma Before It Starts: How Close Are We to Genetic Risk Scores That Actually Change Patient Outcomes?
|
Feb 01, 2026 |
|
Glaucoma Clinical Trials Launched in 2025: A Complete Overview
|
Jan 31, 2026 |
|
Patterns of Vision Loss in Glaucoma: Large Blind Spots Versus Scattered Missing Points
|
Jan 30, 2026 |
|
How Fast Is AI Actually Progressing, and What Does It Mean for Glaucoma Patients and Researchers?
|
Jan 29, 2026 |
|
AI in Glaucoma: What's Working Now, What's Coming Next, and Where the Real Opportunities Lie
|
Jan 28, 2026 |
|
Glaucoma Vision Restoration: What's New in January 2026
|
Jan 26, 2026 |
|
Hydrogen Water Research Compiled: Studies, Dosages, Applications, and Outcomes
|
Jan 25, 2026 |
|
Pyruvate Supplementation for Glaucoma: Comparing Forms, Efficacy, and Global Availability
|
Jan 24, 2026 |
|
Nitric Oxide Pathway Supplements (L-Arginine, L-Citrulline) and Aqueous Outflow
|
Jan 23, 2026 |
|
Pyrroloquinoline Quinone (PQQ) and Mitochondrial Biogenesis in RGCs
|
Jan 22, 2026 |
|
Myopia and Glaucoma: When Nearsightedness Raises the Stakes
|
Jan 21, 2026 |
|
HDL cholesterol and apolipoprotein A-I: protective or paradoxical in glaucoma?
|
Jan 20, 2026 |
|
Complement proteins C3 and C4: systemic innate immunity and glaucoma progression
|
Jan 19, 2026 |
|
Systemic immune-inflammation index (SII) and the speed of RNFL loss
|
Jan 18, 2026 |
|
Coagulation markers (fibrinogen and D-dimer) and optic nerve microthrombosis
|
Jan 17, 2026 |
|
Redox Balance and Glaucoma: Is More Antioxidants Always Better for Your Eyes?
|
Jan 16, 2026 |
|
Red cell distribution width as a microvascular stress marker in glaucoma
|
Jan 16, 2026 |
|
Beyond the Marketing: Which Hydrogen Water Bottles Have Verified Test Results?
|
Jan 15, 2026 |
|
Hydrogen Water Buying Guide for Glaucoma-Focused Consumers: Science-First Approach
|
Jan 14, 2026 |
|
High-Sensitivity CRP: Systemic Inflammation and Glaucoma Neurodegeneration
|
Jan 13, 2026 |
|
ApoB, ApoA1, and Non-HDL Cholesterol: Refining Atherogenic Risk in Glaucoma Patients
|
Jan 12, 2026 |
|
Platelet Metrics (Mean Platelet Volume) and Microvascular Risk in Glaucoma
|
Jan 11, 2026 |
|
Uric Acid: Antioxidant Versus Pro-oxidant in Glaucoma
|
Jan 10, 2026 |
|
IGF-1, mTOR Signaling, and Neurodegeneration Across Eye and Brain
|
Jan 09, 2026 |
|
Oxidative Stress Biomarkers, HRV, and Retinal Ganglion Cell Loss
|
Jan 08, 2026 |
|
Stacking Blood-Thinning Supplements: Cumulative Bleeding Risk in Glaucoma Patients
|
Jan 08, 2026 |
|
Selective Laser Trabeculoplasty in the Era of OTC Blood Thinners: Hyphema and IOP Spikes
|
Jan 07, 2026 |
|
SLT as First-Line Therapy: Who Benefits and When to Repeat
|
Jan 07, 2026 |
|
Neuroprotection Beyond Pressure: What’s Real, What’s Hype
|
Jan 06, 2026 |
|
Dry Eye Can Fake Progression: Fix the Surface, Fix the Tests
|
Jan 05, 2026 |
|
Contact Lenses With Glaucoma: Timing Drops, Preservatives, and Comfort
|
Jan 04, 2026 |
|
Adherence That Sticks: Storage, Travel, and Tech Tools for Glaucoma Drops
|
Jan 03, 2026 |
|
Vasospasm, Cold Hands, and Normal-Tension Glaucoma: The Raynaud’s Connection
|
Jan 02, 2026 |
|
Exercise Smart: Aerobic vs Weightlifting, Valsalva, and Yoga Inversions
|
Dec 31, 2025 |
|
Sleep Posture Hacks: Head Elevation and Side-Sleeping Effects on Eye Pressure
|
Dec 30, 2025 |
|
The Nighttime Blood Pressure Dip: A Hidden Driver in Normal-Tension Glaucoma
|
Dec 30, 2025 |
|
Measuring What Matters: Beyond Visual Fields to Functional Vision
|
Dec 29, 2025 |
|
Hydration Habits: Water-Drinking Spikes and How to Sip Safely
|
Dec 29, 2025 |
|
Mastering Eye Drop Technique: Nasolacrimal Occlusion to Boost Efficacy and Safety
|
Dec 26, 2025 |
|
Vitamins C and E in Glaucoma: Antioxidants Revisited
|
Dec 23, 2025 |
|
Mirtogenol (Pycnogenol + Bilberry) and Eye Pressure: A Critical Appraisal
|
Dec 22, 2025 |
|
Caffeine, Coffee, and Tea: How Do They Impact Eye Pressure?
|
Dec 21, 2025 |
|
Palmitoylethanolamide (PEA) as an Adjunct in Glaucoma
|
Dec 21, 2025 |
|
Can Restoring Ocular Perfusion Restore Vision? OCT-A and Vascular Therapies
|
Dec 20, 2025 |
|
Cortical Plasticity and Perceptual Learning: Can the Brain Compensate for Optic Nerve Damage?
|
Dec 19, 2025 |
|
ROCK Inhibitors Beyond IOP: Axonal Regrowth, Perfusion, and Neuroprotection
|
Dec 19, 2025 |
|
Brain Stimulation for Glaucoma: tDCS, TMS, and Visual Cortex Modulation
|
Dec 18, 2025 |
|
Circadian Biology, ipRGCs, and Neuroprotection in Glaucoma
|
Dec 18, 2025 |
|
The 2024–2025 Pipeline for IOP-Independent Neuroprotection in Glaucoma
|
Dec 17, 2025 |
|
Forecasting Glaucoma Vision Restoration: 5-, 10-, and 20-Year Outlook
|
Dec 17, 2025 |
|
Nicotinamide and Mitochondrial Rescue: Can Metabolic Therapy Restore Function?
|
Dec 16, 2025 |
|
Artificial Vision for End-Stage Glaucoma: Retinal vs. Cortical Prostheses
|
Dec 16, 2025 |
|
Stem Cell–Derived RGC Transplantation: From Petri Dish to Optic Tract
|
Dec 15, 2025 |
|
Electrical Stimulation for Glaucoma: Signal Boost or True Neurorestoration?
|
Dec 15, 2025 |
|
Gene Therapy for Optic Nerve Regeneration: Modulating PTEN/mTOR, KLFs, and Sox11
|
Dec 14, 2025 |
|
Quercetin and Fisetin as Candidate Senolytics in Optic Nerve Aging
|
Dec 14, 2025 |
|
Citrus Bioflavonoids (Hesperidin, Diosmin) for Ocular Hemodynamics
|
Dec 14, 2025 |
|
Molecular Hydrogen and Redox Signaling in Ocular Neuroprotection
|
Dec 13, 2025 |
|
Anthocyanins and Bilberry Extracts: Retinal Resilience and Aging Microvasculature
|
Dec 13, 2025 |
|
Taurine and Retinal Ganglion Cell Survival Across the Lifespan
|
Dec 12, 2025 |
|
Green Tea Catechins (EGCG) for Neurovascular Health in Glaucoma and Aging
|
Dec 12, 2025 |
|
Melatonin, Circadian Rhythms, and Nocturnal IOP Dynamics
|
Dec 12, 2025 |
|
The Gut–Eye Axis: Probiotics, Metabolites, and Intraocular Pressure
|
Dec 11, 2025 |
|
Magnesium for Vascular Dysregulation in Glaucoma and Aging Circulation
|
Dec 11, 2025 |
|
Resveratrol and Sirtuin Pathways: From Trabecular Meshwork to Longevity
|
Dec 10, 2025 |
|
Macular Carotenoids (Lutein, Zeaxanthin, Meso-zeaxanthin) Beyond the Macula
|
Dec 10, 2025 |
|
Saffron (Crocins) in Optic Neuroprotection: Translating Retinal Evidence to Glaucoma
|
Dec 09, 2025 |
|
Safety, Interactions, and Regulatory Oversight of Glaucoma Supplements
|
Dec 09, 2025 |
|
Spermidine and Autophagy: A Longevity Nutrient for the Aging Eye
|
Dec 08, 2025 |
|
Curcumin and Curcuminoids: Anti-inflammatory Strategies for Glaucoma Neuroprotection
|
Dec 08, 2025 |
|
Vitamin D Status, Intraocular Pressure, and Neuroinflammation
|
Dec 08, 2025 |
|
N-Acetylcysteine and Glutathione: Fortifying Antioxidant Defenses in the Aging Eye
|
Dec 07, 2025 |
|
From Bench to Bedside: Translating Longevity Pathways to Glaucoma Supplements
|
Dec 07, 2025 |
|
Omega-3 Fatty Acids, Inflammation Resolution, and Glaucoma Progression
|
Dec 06, 2025 |
|
Astaxanthin for Oxidative Stress and Ocular Blood Flow
|
Dec 06, 2025 |
|
Creatine and Energy Buffering in Retinal and Optic Nerve Tissues
|
Dec 06, 2025 |
|
Alpha-Lipoic Acid: Redox Modulation and Neurovascular Support in Glaucoma
|
Dec 06, 2025 |
|
Citicoline (CDP-Choline) for Visual Pathway Support and Cognitive Aging
|
Dec 06, 2025 |
|
Coenzyme Q10 as a Mitochondrial Adjunct in Glaucoma and Lifespan Health
|
Dec 06, 2025 |
|
Ginkgo biloba for Ocular Perfusion and Visual Field Preservation: Promise and Precautions
|
Dec 06, 2025 |
|
B Vitamins, Homocysteine, and Vascular Dysregulation in Glaucoma
|
Dec 06, 2025 |
|
Designing Multi-Ingredient Neuroprotective Formulations for Glaucoma
|
Dec 06, 2025 |
|
Tele-Glaucoma and Home Monitoring in Aging Populations
|
Dec 06, 2025 |
|
Nicotinamide and NAD+ Boosting for Glaucoma Neuroprotection and Healthy Aging
|
Dec 06, 2025 |